Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
THE PURPOSE OF THIS CONTRACT IS TO ENABLE ADVANCED PRECLINICAL DEVELOPMENT OF AN INTRANASAL RECOMBINANT AMEBIASIS VACCINE CONTAINING A LIPOSOMAL ADJUVANT FORMULATION OF CLINICAL TLR4 AND TLR7/8 LIGANDS. is a federal NONE award for National Institutes Of Health Niaid held by Infectious Disease Research Institute. Estimated value $18.8M ($4.9M obligated). Current period of performance ends Aug 31, 2026. Last award drew 24 bidders. Place of performance: SEATTLE WA. Related solicitation HHSNIHNIAIDBAA20171.
THE PURPOSE OF THIS CONTRACT IS TO ENABLE ADVANCED PRECLINICAL DEVELOPMENT OF AN INTRANASAL RECOMBINANT AMEBIASIS VACCINE CONTAINING A LIPOSOMAL ADJUVANT FORMULATION OF CLINICAL TLR4 AND TLR7/8 LIGANDS.
Recompete timing
PublicCurrent PoP ended Aug 31, 2026 (7 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordInfectious Disease Research Institute — $7.9M obligated across 4 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93018C00025?
75N93018C00025 (ENABLE advanced preclinical development of an) is a National Institutes Of Health Niaid award with a potential value of $18.8M, currently held by Infectious Disease Research Institute. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93018C00025?
National Institutes Of Health Niaid awarded 75N93018C00025 to Infectious Disease Research Institute (potential $18.8M).
Who is the incumbent on 75N93018C00025?
Infectious Disease Research Institute is the incumbent with $7.9M across 4 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2026.
When does Infectious Disease Research Institute’s 75N93018C00025 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 75N93018C00025 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.